Trusted Resources
Jun 13, 2017
Laryngotracheal amyloid deposition is an uncommon manifestation of systemic light chain amyloidosis. Diagnostic imaging, such as CT, is useful for suggesting the…
Jun 12, 2017
Hereditary transthyretin-mediated (hATTR) amyloidosis is a progressive disease characterized by deposition of amyloid fibrils in various organs and tissues of the…
Apr 12, 2017
Cardiac amyloidosis occurs because of abnormal protein (amyloid) deposition in the cardiac tissue. Even with advanced diagnostic techniques and treatments, the…
Apr 10, 2017
Introduction:
A systematic literature review on systemic light chain (AL) amyloidosis was conducted in order to understand the disease burden, and identify unmet…
Mar 21, 2017
The role of older generations in families with hereditary diseases has been recognised and associated to their function as guardians of the family's medical history…
Mar 20, 2017
Introduction:
Cardiac amyloidosis (CA) results from myocardial infiltration of amyloid proteins that leads to restrictive cardiomyopathy, heart failure, and…
Mar 16, 2017
You may ask yourself, "Why should I try something that researchers are not sure will work?" That is a good question. Being part of a clinical trial may have risks…
Dec 25, 2016
Systemic light-chain (AL) amyloidosis is an infiltrative disorder associated with an underlying plasma cells dyscrasia, in which monoclonal immunoglobulin light…
Dec 14, 2016
Familial Mediterranean fever (FMF) is divided into two phenotypes: Type 1 and Type 2
* FMF type 1 is characterized by recurrent short episodes of inflammation…
Nov 28, 2016
Systemic amyloidoses are rare and proteiform diseases, caused by extracellular accumulation of insoluble misfolded fibrillar proteins. Prognosis is dictated by…